Benefits
Supports Hair, Skin, and Nail Health
Biotin is a cofactor your body needs to build the fats and amino acid intermediates that hair, skin and nail cells use, so correcting a genuine deficiency restores hair and nail growth. Biotin does not strengthen keratin directly; keratin is not a biotin-dependent protein. In people who are not deficient the evidence is weak. A published review found 18 reported cases of biotin used for hair or nail problems, and in every one the person already had an underlying condition causing poor growth; the authors concluded there is a lack of sufficient evidence for supplementation in healthy individuals (Patel 2017).
Aids Energy Metabolism
Biotin is a cofactor for five carboxylase enzymes that handle carbohydrates, fats and protein. This is basic biochemistry, not a benefit of supplementing: the same is true of the small amount of biotin already in food, and there is no evidence that taking more than you need speeds up energy metabolism or makes you feel more energetic.
Blood Sugar and Blood Fats: Limited Evidence
A 2022 meta-analysis pooled 5 randomized trials with 445 participants who had type 2 diabetes. Only total cholesterol changed by a statistically reliable amount (mean difference -0.22 mmol/L, 95% CI -0.25 to -0.19). The fasting glucose result (-1.21 mmol/L, 95% CI -2.73 to 0.31) and the triglyceride result (-0.59 mmol/L, 95% CI -1.21 to 0.03) both have confidence intervals that cross zero, so neither is statistically significant despite the wording used in the paper. The effect on insulin was not significant and the HbA1c data were too limited to judge. Biotin is not a treatment for diabetes or for high blood sugar.
Supports Nervous System
Biotin-dependent carboxylases work in the brain as they do everywhere else, and severe deficiency can cause neurological symptoms. That is a reason not to be deficient, not evidence that extra biotin improves nerve function in people whose levels are normal. There is no trial showing a nervous system benefit of supplemental biotin in healthy adults.
Pregnancy and Fetal Development
Marginal biotin depletion is common in pregnancy, but what that means for the pregnancy is not established in humans; the birth-defect findings come from animal studies. Pregnancy is a reason to meet normal biotin needs through diet and a prenatal supplement chosen with your clinician, not a reason to take a high-dose beauty product.
Mechanism of action
Cofactor for Carboxylase Enzymes
Biotin is covalently bound to five key carboxylase enzymes: Pyruvate carboxylase, Propionyl-CoA carboxylase, Methylcrotonyl-CoA carboxylase, Acetyl-CoA carboxylase 1 and Acetyl-CoA carboxylase 2. These enzymes catalyze carboxylation reactions, transferring a carboxyl group (CO₂) to substrates, which is critical for metabolic pathways.
Activation via Holocarboxylase Synthetase
Biotin is attached to a lysine residue on these enzymes by the enzyme holocarboxylase synthetase (HCS), forming a biotinylated holoenzyme. This biotinylation is essential for the enzyme's catalytic activity. The biotin molecule acts as a swinging arm, facilitating the transfer of CO₂ from bicarbonate to the substrate.
Gluconeogenesis and Krebs Cycle
Pyruvate carboxylase converts pyruvate to oxaloacetate, a precursor for glucose synthesis and an intermediate in the citric acid cycle.
Fatty Acid Synthesis
Acetyl-CoA carboxylase (1 and 2) catalyzes the formation of malonyl-CoA, a key step in fatty acid biosynthesis and regulation of mitochondrial fatty acid oxidation.
Amino Acid Catabolism
Propionyl-CoA carboxylase and methylcrotonyl-CoA carboxylase are involved in the breakdown of branched-chain amino acids (e.g., leucine, isoleucine) and odd-chain fatty acids.
Energy Metabolism
These carboxylation reactions support energy production and biosynthetic processes by feeding intermediates into central metabolic pathways.
Biotin Cycle and Recycling
Biotin is recycled through the action of biotinidase, which cleaves biotin from biocytin (biotin-lysine complex) or biotinylated peptides during protein turnover, making it available for reuse by HCS. This recycling ensures a steady supply of biotin for carboxylase activity, even with low dietary intake.
Non-Enzymatic Roles (Emerging Evidence)
Biotin may influence gene expression by modifying histones through biotinylation, mediated by HCS or biotinidase, affecting chromatin structure and gene regulation. Later quantitative work found biotinylated histones are extremely rare in cells, so this role is disputed rather than established. Biotin may also play a part in cell signaling and immune function, though those mechanisms are not well established either.
Clinical trials
Randomized, placebo-controlled, double-blind study at one U.S. clinical site evaluating an oral supplement (Viviscal®, containing marine protein complex AminoMar® plus biotin and other nutrients) in 60 healthy women aged 21-75 with self-perceived hair thinning. (Ablon G, Dermatol Res Pract. 2015;2015:841570. 30 women took the supplement and 30 took placebo; no reference for this trial is listed on this page.)
60 women with self-perceived hair thinning. 90-day intervention.
Active group showed significant increase in number of terminal hairs in target area at day 90 vs placebo (p<0.0001). Note: this trial evaluated a multi-ingredient product, not biotin in isolation. The biotin contribution cannot be isolated from marine protein complex effect. Industry-funded.
Evidence review of biotin supplementation for hair and nail growth, conducted via PubMed search of clinical trials and case reports. Outcome: efficacy of biotin in non-deficient populations. (Patel DP, Swink SM, Castelo-Soccio L. A Review of the Use of Biotin for Hair Loss. Skin Appendage Disord. 2017;3(3):166-169. PMID 28879195.)
Pooled across 18 cases of biotin use for hair/nails.
In all 18 reported cases the person already had an underlying condition causing poor hair or nail growth, including acquired or inherited biotin deficiency, brittle nail syndrome and uncombable hair syndrome. These were uncontrolled case reports, not trials. Authors found no high-quality evidence supporting biotin supplementation for hair growth in healthy, non-deficient individuals. So the reported improvement tracks an underlying condition rather than showing a general hair growth effect. Despite this, marketed claims often overstate evidence.
Case series of three children with familial uncombable hair syndrome (a rare hair shaft disorder) treated with biotin supplementation. Hair texture, manageability, and microscopic structure assessed pre/post. (Pediatr Dermatol)
3 children with uncombable hair syndrome.
Improvement in hair manageability after biotin supplementation in all three cases. Note: This is a rare syndrome, not a model for general hair issues. Three uncontrolled cases with no comparison group cannot show that biotin caused the change, and children's hair texture often changes on its own. This page lists no reference for the case series.
Case report of an infant developing biotin deficiency after consumption of a biotin-free amino acid formula. Clinical signs included alopecia, dermatitis, and metabolic acidosis.
Single infant case.
Biotin deficiency manifested as hair loss, scaly dermatitis, and metabolic abnormalities. Resolved with biotin supplementation. Demonstrates the syndromic presentation of biotin deficiency. Note: dietary biotin deficiency is rare in normal populations. Pregnant women, people on long-term anticonvulsants, and newborns with inherited biotinidase deficiency are at higher risk. Biotinidase deficiency responds to biotin and is managed by a doctor, not with over-the-counter beauty doses.
Non-randomized, uncontrolled pilot study in 23 patients with progressive multiple sclerosis receiving 100-300 mg/day biotin (~10,000× RDA). Outcomes: clinical disability, ambulation, visual function. (Mult Scler Relat Disord)
23 progressive MS patients. Open-label.
Initial pilot suggested clinical improvement in some patients. Note: this triggered the larger MD1003 (high-dose biotin) program. Subsequent Phase 3 clinical trials (SPI2 trial, 2020) failed to show benefit on the primary endpoint, leading to discontinuation of the program. The early pilot data turned out not to translate to controlled trials. High-dose biotin can also cause critical lab interference with thyroid, troponin, and hormone immunoassays. High-dose biotin is not used clinically for multiple sclerosis.
Two small studies sit behind this card. A retrospective review of one nail consultation practice followed 35 adults who took biotin 2.5 mg/day for 6 to 9 months and were assessed by subjective report (Hochman 1993, Cutis). The outcome in that review was patient-reported nail brittleness. A separate scanning electron microscopy study measured nail plate thickness in a small number of treated patients (Colombo 1990, J Am Acad Dermatol). Neither study had a placebo group, and this page lists no reference for either.
35 adults with onychoschizia or brittle nails, 6 to 9 months, no control group.
22 of 35 patients (63%) reported improvement and 13 (37%) reported no change; this was self-reported, not measured. The increase in nail thickness seen by microscopy comes from the separate electron microscopy study, not from these 35 patients. Note: without a placebo group, regression to the mean and normal variation in nail growth cannot be excluded. No dermatology guideline recommends biotin for nails. Reviews of brittle nails list it among options reported to be useful, but recent reviews conclude the evidence is too weak to support routine use in people who are not deficient.
Evidence review and pooled analysis of randomized controlled trials evaluating biotin supplementation effects on glycemic control (FPG, HbA1c) and lipid profile in patients with type 2 diabetes. (Zhang Y, Ding Y, Fan Y, et al. Front Nutr. 2022;9:1046800. PMID 36386951. 5 randomized trials, 445 participants, 28 to 90 days of biotin.)
445 adults with type 2 diabetes pooled across 5 randomized trials.
Read the numbers carefully. Fasting blood glucose fell by a mean of 1.21 mmol/L but the 95% confidence interval ran from -2.73 to 0.31, and triglycerides fell 0.59 mmol/L with an interval of -1.21 to 0.03. Both intervals cross zero, so neither result is statistically significant even though the paper's own wording calls them significant. Only total cholesterol excluded zero (-0.22 mmol/L, 95% CI -0.25 to -0.19), and that is a very small change. The effect on insulin was not significant, and the authors said the HbA1c evidence was too limited to draw a conclusion. A mechanism through pyruvate carboxylase and insulin secretion has been proposed, but with the glucose result not statistically significant there is little effect for it to explain. Effect sizes generally small; biotin is not a substitute for established diabetes therapies.